The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use

Cytotherapy

Volumn 9, Issue 4, 2007, Pages 328-337

  Haack Sorensen, M ^a   Bindslev, L ^a   Mortensen, S ^a   Friis, T ^a   Kastrup, J ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Cell cultures; Endothelial differentiation; Mesenchymal stromal cells; Stem cell therapy; VEGF

Indexed keywords

ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPRESERVATION; DEGENERATIVE DISEASE; ENDOTHELIUM CELL; HEART DISEASE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CRYOPRESERVATION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; FREEZING; GENE EXPRESSION REGULATION; HUMANS; MESODERM; STROMAL CELLS; SURFACE PROPERTIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34347250811     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701322235     Document Type: Article

References (36)

1. Heeschen, C., Lehmann, R. and Honold, J. (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109, pp. 1615-1622.
2. Perin, EC, Geng, YJ and Willerson, JT. (2003) Adult stem cell therapy in perspective. Circulation, 107, pp. 935-938.
3. Kassem, M., Kristiansen, M. and Abdallah, BM. (2004) Mesenchymal stem cells: Cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol, 95, pp. 209-214.
4. Bacigalupo, A. (2004) Mesenchymal stem cells and haematopoietic stem cell transplantation. Best Pract Res Clin Haematol, 17, pp. 387-399.
5. Le, BK and Pittenger, M. (2005) Mesenchymal stem cells: Progress toward promise. Cytotherapy, 7, pp. 36-45.
6. Pittenger, MF, Mackay, AM and Beck, SC (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, pp. 143-147.
7. Reyes, M., Dudek, A. and Jahagirdar, B. (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest, 109, pp. 337-346.
8. Toma, C., Pittenger, MF and Cahill, KS (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, pp. 93-98.
9. Tomita, S., Mickle, DA and Weisel, RD (2002) Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg, 123, pp. 1132-1140.
10. Shake, JG, Gruber, PJ and Baumgartner, WA (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg, 73, pp. 1919-1925.
11. Nagaya, N., Kangawa, K. and Itoh, T. (2005) Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112, pp. 1128-1135.
12. Bittira, B., Shum-Tim, D., Al-Khaldi, A. and Chiu, RC. (2003) Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur J Cardiothorac Surg, 24, pp. 393-398.
13. Shyu, KG, Wang, BW and Hung, HF (2006) Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. J Biomed Sci, 13, pp. 47-58.
14. Al-Khaldi, A., Al-Sabti, H., Galipeau, J. and Lachapelle, K. (2003) Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg, 75, pp. 204-209.
15. Haack-Sorensen, M., Friis, T. and Bindslev, L. (2007) Comparison of culture conditions for human mesenchymal stem cells for clinical stem cell therapy. Cell Biol Internat
16. Bindslev, L., Haack-Sorensen, M. and Bisgaard, K. (2006) Labeling of human mesenchymal stem cells with indium-111 for SPECT imaging: Effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging, 33, pp. 1171-1177.
17. Kicic, A., Hall, CM, Shen, WY and Rakoczy, PE. (2005) Are stem cell characteristics altered by disease state?. Stem Cells Dev, 14, pp. 15-28.
18. Yeo, TP. (2004) Heal thyself: Potential applicability of stem cell therapy in the management of heart disease. J Cardiovasc Nurs, 19, pp. 396-403.
19. Lee, MS, Lill, M. and Makkar, RR. (2004) Stem cell transplantation in myocardial infarction. Rev Cardiovasc Med, 5, pp. 82-98.
20. Colter, DC, Class, R., DiGirolamo, CM and Prockop, DJ. (2000) Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA, 97, pp. 3213-3218.
21. Lagar'kova, MA, Lyakisheva, AV and Filonenko, ES (2006) Characteristics of human bone marrow mesenchymal stem cells isolated by immunomagnetic selection. Bull Exp Biol Med, 141, pp. 112-116.
22. Simmons, PJ and Torok-Storb, B. (1991) Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 78, pp. 55-62.
23. + fraction of adult human bone marrow contains the osteogenic precursors. Blood, 84, pp. 4164-4173.
24. Haynesworth, SE, Baber, MA and Caplan, AI. (1996) Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha. J Cell Physiol, 166, pp. 585-592.
25. Bruder, SP, Horowitz, MC, Mosca, JD and Haynesworth, SE. (1997) Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone, 21, pp. 225-235.
26. Barry, FP, Boynton, RE and Haynesworth, S. (1999) The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun, 265, pp. 134-139.
27. Barry, F., Boynton, R., Murphy, M., Haynesworth, S. and Zaia, J. (2001) The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun, 289, pp. 519-524.
28. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L. and Verfaillie, C. (2001) Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 98, pp. 2615-2625.
29. Kim, DH, Yoo, KH and Choi, KS (2005) Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine, 31, pp. 119-126.
30. Barry, FP. (2003) Biology and clinical applications of mesenchymal stem cells. Birth Defects Res C Embryo Today, 69, pp. 250-256.
31. Oswald, J., Boxberger, S. and Jorgensen, B. (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells, 22, pp. 377-384.
32. Taylor, MJ, London, NJ and Thirdborough, SM (1990) The cryobiology of rat and human dendritic cells: Preservation and destruction of membrane integrity by freezing. Cryobiology, 27, pp. 269-278.
33. Taylor, MJ, Foreman, J., Biwata, Y. and Tsukikawa, S. (1992) Prolongation of islet allograft survival is facilitated by storage conditions using cryopreservation involving fast cooling and/or tissue culture. Transplant Proc, 24, pp. 2860-2862.
34. Ketheesan, N., Kearney, JN and Ingham, E. (1996) The effect of cryopreservation on the immunogenicity of allogeneic cardiac valves. Cryobiology, 33, pp. 41-53.
35. Ketheesan, N., Whiteman, C. and Malczewski, AB (2004) Effect of cryopreservation on the immunogenicity of umbilical cord blood cells. Transfus Apher Sci, 30, pp. 47-54.
36. Rust, PA, Costas, C. and Cannon, SR (2006) Characterisation of cryopreserved cells freshly isolated from human bone marrow. Cryo Lett, 27, pp. 17-28.